DEF 14AThe Ballot
Entrada Therapeutics, Inc. files DEF 14A
Filed Apr 25, 2023 · 3y ago · Accession 0001104659-23-049258
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Entrada Therapeutics, Inc.
- Ticker
- TRDA
- CIK
- 1689375
- Form type
- DEF 14A
- Filing date
- Apr 25, 2023
- Report date
- Jun 8, 2023
- Document
- tm232134-1_def14a.htm
- Size
- 1.5 MB